The Association of Clinical Research Professionals (ACRP) announces a new webinar series, in conjunction with the U.S. Food and Drug Administration (FDA), addressing strategies for increasing engagement, recruitment and retention of diverse populations of women in clinical trials.
FDA Commissioner Robert M. Califf, MD, will provide webinar attendees with an overview of FDA's commitment to increasing participation of diverse populations of women in clinical trials. Dr. Califf has designated 2016 "the year of diversity in clinical trials."
"We are thrilled to be working in conjunction with the FDA in support of its initiatives to increase diversity in clinical trial participation," says Jim Kremidas, ACRP Executive Director. "This is an excellent opportunity for ACRP members to understand and prepare for challenges on the horizon while learning practical strategies that can be implemented today to increase diversity in clinical trial participation."
Planning for Diversity, November 1, 2016
Attendees will learn new approaches to boost recruitment and retention by creating research environments that foster effective communication and outreach to diverse populations of women.
Speakers include Marjorie Jenkins, MD, MEd, FACP, Director of Medical Initiatives and Scientific Engagement, Office of Women's Health, FDA, and Aisha Langford, PhD, MPH, Assistant Professor of Population Health, New York University School of Medicine.
Recruitment and Retention, November 9, 2016
Attendees will learn practical strategies for overcoming the barriers that can derail recruitment and retention of diverse populations of women.
Speakers include Marsha Henderson, MCRP, Assistant Commissioner for Women's Health, FDA, and Carol Horowitz, MD, Associate Professor of Medicine and Health Policy, Mount Sinai School of Medicine.
In addition to this series on diverse populations of women in clinical trials, ACRP, in conjunction with FDA, will offer a third webinar on FDA BIMO Compliance and Enforcement of Drugs and Devices.
FDA BIMO Compliance and Enforcement of Drugs and Devices, November 16
Attendees will learn best practices for preparing for FDA inspections and key strategies for responding to Form FDA 483s.
Speakers include David Burrow, PharmD, JD, Acting Director of the Office of Scientific Investigations, Center for Drug Evaluation and Research Office of Compliance, FDA, and CDR Tamika Allen, MS, RN, Senior Regulatory Operations Officer and Premarket Team Lead, Center for Devices and Radiological Health Division of Bioresearch Monitoring, FDA
All three webinars will provide attendees with continuing education credits.